Skip to main content
Fig.1 | Gut Pathogens

Fig.1

From: A triad of gut dysbiosis, dysregulated immunity, and ‘leaky’ gut characterize HCMV associated neonatal cholestasis

Fig.1

Estimation of fecal microbial products– (A) Levels of fecal short-chain fatty acids assessed by HPLC and fecal LPS by ELISA in HCMV infected infants (N = 15 each) with NC compared to healthy controls (N = 10) along with significant ROC curve analysis for butyrate and LPS; (B) Relative proportion of predicted significant Metacyc pathways associated with SCFA synthesis obtained by PICRUSt2 analysis. Data represented as Median. Statistical significance calculated by Kruskal –Wallis test with Dunn’s multiple comparison test; *, p < 0.05; **, p < 0.01, ***, p < 0.001; and ****, p < 0.001

Back to article page

Gut Pathogens

ISSN: 1757-4749